We now have a dedicated Regulatory Roundup page: a repository of earlier Roundup materials as well as the latest and greatest from any given quarter. If you're interested primarily in the current newest elements, pay particular attention to the DHC FDA-guidance related articles (a compilation of FDA Guidance Doc articles written by DHC regulatory experts), BLA review updates (the latest from Q2 of this year), and FDA Guidance Docs (new this Q). This page will be updated every quarter.
Subscribe to our mailing list for the latest insights on advanced therapy development, regulatory updates, industry trends, and upcoming events from Dark Horse Consulting Group.
We respect your privacy. Unsubscribe at any time. We will never sell your information.